BlackRock’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-153,756
| Closed | -$50.7K | – | 5766 |
|
|
2025
Q4 | $50.7K | Hold |
153,756
| – | – | ﹤0.01% | 5054 |
|
|
2025
Q3 | $31.1K | Hold |
153,756
| – | – | ﹤0.01% | 5069 |
|
|
2025
Q2 | $41.5K | Hold |
153,756
| – | – | ﹤0.01% | 5026 |
|
|
2025
Q1 | $30.4K | Hold |
153,756
| – | – | ﹤0.01% | 5018 |
|
|
2024
Q4 | $35.4K | Hold |
153,756
| – | – | ﹤0.01% | 5021 |
|
|
2024
Q3 | $15.1K | Hold |
153,756
| – | – | ﹤0.01% | 4964 |
|
|
2024
Q2 | $24.6K | Hold |
153,756
| – | – | ﹤0.01% | 4983 |
|
|
2024
Q1 | $46.5K | Hold |
153,756
| – | – | ﹤0.01% | 4886 |
|
|
2023
Q4 | $9.22K | Hold |
153,756
| – | – | ﹤0.01% | 5151 |
|
|
2023
Q3 | $15.4K | Hold |
153,756
| – | – | ﹤0.01% | 5171 |
|
|
2023
Q2 | $25.4K | Sell |
153,756
-2,146
| -1% | -$335 | ﹤0.01% | 5174 |
|
|
2023
Q1 | $18.7K | Hold |
155,902
| – | – | ﹤0.01% | 5262 |
|
|
2022
Q4 | $22.5K | Hold |
155,902
| – | – | ﹤0.01% | 5366 |
|
|
2022
Q3 | $27K | Hold |
155,902
| – | – | ﹤0.01% | 5466 |
|
|
2022
Q2 | $44K | Hold |
155,902
| – | – | ﹤0.01% | 5436 |
|
|
2022
Q1 | $118K | Sell |
155,902
-75,264
| -33% | -$75.8K | ﹤0.01% | 5246 |
|
|
2021
Q4 | $437K | Sell |
231,166
-2,165
| -0.9% | -$4.91K | ﹤0.01% | 4906 |
|
|
2021
Q3 | $589K | Hold |
233,331
| – | – | ﹤0.01% | 4709 |
|
|
2021
Q2 | $608K | Hold |
233,331
| – | – | ﹤0.01% | 4648 |
|
|
2021
Q1 | $623K | Buy |
+233,331
| New | +$675K | ﹤0.01% | 4582 |
|
BlackRock's NUVB.WS Position: Q1 2026 in Review
BlackRock sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q1 2026, closing a stake of 153,756 shares — an estimated $50.7K sold.
BlackRock first reported a position in NUVB.WS in Q1 2021 and held it in 20 quarters. The position peaked at $623K in Q1 2021. 0 funds tracked by Wall St. Rank hold NUVB.WS as of Q1 2026.
- BlackRock reported no remaining Nuvation Bio Inc Warrants position as of Q1 2026 after selling out during the quarter.
- BlackRock sold 153,756 Nuvation Bio Inc Warrants shares in Q1 2026, an estimated $50.7K.
- BlackRock first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 20 quarters.
- BlackRock's Nuvation Bio Inc Warrants position peaked at $623K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.